Atorvastatin cuts anthracycline heart failure

Published Date: 08 Mar 2023

Atorvastatin 40 mg daily for 12 months reduces cardiovascular events in lymphoma patients treated with anthracyclines.

Read Full News

Latest News

Therapy-Intense Training Linked to Improved Sleep Outcomes

Combining high-intensity circuit training with a sleep health program is tied to better sleep outcomes in sedentary women than either intervention alone, a new study shows.

AHA, ACC Issue Comprehensive Guidelines on Acute PE

The first multisociety guidelines on the diagnosis and management of acute pulmonary embolism feature a new classification system.

Paclitaxel Devices Should Not Be Routine for Claudication

An MHRA advisory group says paclitaxel-coated balloons and stents should not be used routinely for intermittent claudication over mortality concerns.

Ramipril Batch Recalled After Amlodipine Found in Packs

The MHRA has recalled a batch of ramipril after a packaging error meant some cartons contained amlodipine tablets instead of the labelled medicine.

The Many Cardiovascular Benefits of GLP-1 Drugs

Diabetes and obesity drugs also lead to large reductions in adverse cardiovascular events, and the benefits aren’t just down to weight loss.

Aspirin May Reduce Aortic Stenosis in People With High Lp(a)

New evidence shows regular aspirin use is associated with a lower incidence of aortic valve calcification and aortic stenosis, specifically in people with high lipoprotein(a).

Todays Updates

Have the Harms of Lung Cancer Screening Been Exaggerated?

Three medical societies claim recent studies have overestimated the potential harms from lung cancer screening and may be deterring patients. Not everyone agrees.

Pretreatment Liver Tests Often Overlooked in CDK4/6 Therapy

Despite FDA package insert recommendations, most patients with breast cancer who are prescribed CDK4/6 inhibitors do not receive liver function tests before starting treatment.

Alternative Medicine for Breast Cancer: Study Raises Concern

Patients who receive both standard medical treatment and complementary and alternative therapies have higher mortality — possibly due to reduced use of endocrine therapy and radiation.

Todays Updates

Have the Harms of Lung Cancer Screening Been Exaggerated?

Three medical societies claim recent studies have overestimated the potential harms from lung cancer screening and may be deterring patients. Not everyone agrees.

Pretreatment Liver Tests Often Overlooked in CDK4/6 Therapy

Despite FDA package insert recommendations, most patients with breast cancer who are prescribed CDK4/6 inhibitors do not receive liver function tests before starting treatment.

Alternative Medicine for Breast Cancer: Study Raises Concern

Patients who receive both standard medical treatment and complementary and alternative therapies have higher mortality — possibly due to reduced use of endocrine therapy and radiation.

Latest News

Combining high-intensity circuit training with a sleep health program is tied to better sleep outcomes in sedentary women than either intervention alone, a new study shows.

The first multisociety guidelines on the diagnosis and management of acute pulmonary embolism feature a new classification system.

An MHRA advisory group says paclitaxel-coated balloons and stents should not be used routinely for intermittent claudication over mortality concerns.

The MHRA has recalled a batch of ramipril after a packaging error meant some cartons contained amlodipine tablets instead of the labelled medicine.

Diabetes and obesity drugs also lead to large reductions in adverse cardiovascular events, and the benefits aren’t just down to weight loss.

New evidence shows regular aspirin use is associated with a lower incidence of aortic valve calcification and aortic stenosis, specifically in people with high lipoprotein(a).

News All Time

Smartwatch Hypertension Alerts Shouldn’t Replace Screening

Receiving an alert increased the probability of undiagnosed hypertension, but absence of an alert did not reliably rule it out and should not replace cuff-based screening.

Can Drug-Eluting Balloons Challenge Stents in STEMI?

Proponents argue drug-eluting balloons avoid permanent implants and may shorten dual antiplatelet therapy, whereas critics warn of vessel dissection and the need for bailout stenting.

Patients and GPs Unite Over NHS ‘Maze’

GPs are spending up to a third of their time on paperwork, as patients and doctors warn that NHS bureaucracy is undermining care.

Gear Up Now for Daylight Savings Time: Five Steps

Take these steps to get you and your patients ready to transition to your new local time with minimal adverse health effects.

Low-Risk TAVR Matches SAVR at 6 Years; Reinterventions Rise

Six-year follow-up from a trial comparing surgery with TAVR in low-risk patients showed no difference in major events, but the reintervention was higher in the TAVR arm.

Are Visual Deficits After Stroke Being Missed?

The European Stroke Organization calls for systematic screening within days of stroke to detect visual deficits that affect up to three quarters of survivors.

Is Stroke Underrecognized After Snakebite?

Experts call for urgent neuroimaging access, structured referral pathways, and standardized protocols to reduce disability and deaths following snake envenoming.

Off-Pump Beats On-Pump CABG in Short-Term Outcomes

Perioperative morbidity and mortality were reduced with off-pump vs on-pump coronary artery bypass grafting, though survival evened out over the long term.

Universities Unite to Tackle CVD Inequality

A £50 million research partnership will target heart health gaps affecting deprived communities, ethnic minority groups, and women in the UK.

Heart Symptoms Common in Seniors Without Cardiac Disease

Older adults with no diagnosis of cardiac disease often experience heart-related symptoms such as fatigue, exertional shortness of breath, and tachycardia, which are linked to poor quality of life.

CKM Syndrome Recognition and Collaboration Gaining Traction

While first-ever guidelines are in the works, experts across specialties share their take on the current state of preventing, diagnosing, and managing CKM syndrome.

CT-Quantified Plaque Volume May Predict CAD

Plaque burden predicts major adverse cardiac events, independent of other risk factors.

EMA Rejects Drugs for Rett Syndrome, Schizophrenia

Daybue was turned down for Rett syndrome, and Iloperidone for schizophrenia and bipolar I, with safety and benefit-risk concerns cited in both cases.

Resuscitation’s Ethical Dilemma: Rethink Epinephrine Use

Epinephrine improves ROSC in cardiac arrest but does not increase favorable neurologic recovery, raising ethical and guideline questions for clinicians.

Bariatric Surgery Beats GLP-1s for Heart Protection in T2D

A meta-analysis of 11 studies involving over 19,000 patients with T2D and obesity shows that bariatric surgery provides greater cardiovascular protection and mortality reduction than GLP-1 drugs.

Tenecteplase May Help Stroke Recovery Past 4.5-Hour Window

Some patients with a common type of stroke benefit from a clot-busting drug given between 4.5 and 24 hours after symptoms emerged, according to a new study.

Recommended News For You

According to a study, breast cancer in Syrian refugees tends to be diagnosed at an earlier stage and with more advanced tumors.

A new drug delivery system may help patients with a rare eye cancer

UK government can save lives and smash inequalities by changing prostate cancer guidelines, say experts

Safe and acceptable telehealth suicide prevention program.

There is a 40% reduction in the risk of 9 cancers with good cardiorespiratory fitness.

Quality of Life Similar With Proton Beam Therapy vs IMRT for Prostate Cancer

Words matter to people living with cancer. Here's how verbal microaggressions affect their mental state

Recommended Articles For You

AI in Genomics: Decoding the Human Genome for Cancer Treatment 

Polycythemia Vera: A Historical Perspective and Contemporary Management 

Unlocking the Potential of Reticulocytes: The Key to Enhanced Blood Production 

Unlocking the Potential of Immune Checkpoint Inhibitors: A Pioneering Case Series on the Role of Immunotherapy in Microsatellite-Instability-High Colorectal Cancer 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

In Advanced Myxoid Liposarcoma, Is Trabectedin Winning?

2.

Efficacy and safety of intravenous chemotherapy in children with intraocular retinoblastoma

3.

Tafasitamab-Based Combination Boosts PFS in Relapsed/Refractory Follicular Lymphoma

4.

ACS Guidelines Expand Lung Cancer Screening Eligibility -- Is That a Good Thing?

5.

Alarm Over Pharma-China Link; Taking Screening to the People; Agriculture and Cancer

1.

Liquid Biopsy in SCLC: cfDNA Profiling for Diagnosis and Treatment Monitoring

2.

Liquid Biopsy: A Revolutionary Tool for Early Detection and Monitoring of Colorectal Cancer

3.

Managing High Potassium Levels: A Comprehensive Guide to Veltassa 

4.

Beyond the Organs: Navigating the Era of Tissue-Agnostic Therapies in Modern Cancer Management

5.

Case Study: Advancing Preclinical Oncology Drug Development with Quantitative Systems Pharmacology

1.

International Lung Cancer Congress®

2.

Future NRG Oncology Meeting

3.

Genito-Urinary Oncology Summit 2026

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part IV

2.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VII

3.

Unmet Needs in ALK Positive NSCLC- The Challenges in the Current Care

4.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part II

5.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part V

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot